| 1 |
Lee HY, Oh BH. Heart transplantation in asia[J]. Circ J, 2017, 81(5): 617-621.
|
| 2 |
中华医学会器官移植学分会. 中国心脏移植受者术前评估与准备技术规范(2019版)[J/CD]. 中华移植杂志：电子版，2019, 13(1): 1-7.
|
| 3 |
Israni AK, Zaun DA, Rosendale JD, et al. OPTN/SRTR 2013 Annual Data Report: deceased organ donation[J]. Am J Transplant, 2013, 15 (Suppl 2): S1-S13.
|
| 4 |
黄洁. 阜外医院200例心脏移植病人中期生存率和影响因素与ISHLT结果对比分析研究[D]. 北京：北京协和医学院，2010.
|
| 5 |
Lietz K, John R, Mancini DM, et al. Outcomes in cardiac transplant recipients using allografts from older donors versus mortality on the transplant waiting list：implications for donor selection criteria[J]. J Am Coll Cardiol, 2004, 43(9): 1553-1561.
|
| 6 |
唐玉荣，向桂玉. 心脏移植术中供心的保护[J]. 中华器官移植杂志，1999, 10(4): 232-233.
|
| 7 |
Wei J, Chang CY, Chuang YC. Successful heart transplantation after 13 hours of donor heart ischemia with the use of HTK solution：a case report[J]. Transplant Proc, 2005, 37(5): 2253-2254.
|
| 8 |
Valluvan J, Satoshi F, Thomas WP, et al. Standard criteria for an acceptable donor heart are restricting heart transplantation[J]. Ann Thorac Surg, 1996, 62(5): 1268-1275.
|
| 9 |
国家卫生和计划生育委员会，公安部，交通运输部，等. 关于建立人体捐献器官转运绿色通道的通知[EB/OL]. (2016-05-06)[2019-12-11].
URL
|
| 10 |
Hachida M, Ookado A, Nonoyama M. Effect of HTK solution for myocardial preservation[J]. J Cardiovasc Surg (Torino), 1996, 37(3): 269-274.
|
| 11 |
Hendry PJ, Labow RS, Keon WJ, et al. A comparison of intracellular solution for donor heart preservation[J]. J Thorac Cardiovasc Surg, 1993, 105(4): 667-673.
|
| 12 |
Saitoh Y, Hashimoto M, Ku K, et al. Heart preservation in HTK solution: role of coronary vasculature in recovery of cardiac function[J]. Ann Thorac Surg, 2000, 69(1): 107-112.
|
| 13 |
Yang Q, Zhang RZ, Yim AP, et al. Histidine-tryptophan-ketoglutarate solution maximally preserves endothelium-derived hyperpolarizing factor-mediated function during heart preservation: comparison with University of Wisconsin solution[J]. J Heart Lung Transplant, 2004, 23(3): 352-359.
|
| 14 |
Mokbel M, Zamani H, Lei L, et al. Histidine-tryptophan-ketoglutarate solution for donor heart preservation is safe for transplantation[J]. Ann Thorac Surg, 2019, 109(3): 763-770.
|
| 15 |
王蕾，杨立平. 心脏瓣膜手术中HTK液与含血停搏液心肌保护效果的比较[J]. 福建医科大学学报，2019, 53(5): 338-341.
|